Inhibitor reabsorptionis serotonini noradrenalinique

E Vicipaedia
Synapsis chemica: post liberationem neurotransmissoris reabsorptio per transportatorem ("neurotransmitter transporter") perficitur.

Inhibitores reabsorptionis serotonini noradrenalinique (IRSN, abbreviatura anglica: SNRI) sunt grex medicamentorum cum effectibus praecipue antidepressivis. Nonnulli IRSN ad alios morbos (per exemplum neuropathiam diabeticam, obesitatem) tractandos illati sunt. IRSN transportatores serotonini (SERT) atque noradrenalini (NET) in functionibus reabsorptionis transmissorum suorum obtundunt[1].

Inhibitores reabsorptionis serotonini noradrenalinique sunt

Notae[recensere | fontem recensere]

  1. ↑ Cashman JR, Ghirmai S (2009). "Inhibition of serotonin and norepinephrine reuptake and inhibition of phosphodiesterase by multi-target inhibitors as potential agents for depression". Bioorganic Medic Chem 17: 6890-7 

Nexus interni

Receptum de "https://la.wikipedia.org/w/index.php?title=Inhibitor_reabsorptionis_serotonini_noradrenalinique&oldid=3537807"